A comparison of health care costs in patients with psoriatic arthritis (PSA) who received etanercept (ETA), ETA plus methotrexate (MTX), infliximab (INF), or inf plus MTX

被引：0
|
作者：
Dabbous, O.
Rahman, M.
Meissner, B. L.
Thompson, H.
Tang, B.
机构：
[1] Gentocor Inc, Horsham, PA USA
[2] Xcenda, Palm Harbor, FL USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68898-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A118 / A119
页数：2
相关论文
共 15 条
  • [1] Comparison of healthcare costs in patients with psoriatic arthritis who received etanercept, etanercept plus methotrexate, infliximab, or infliximab plus MTX
    Dabbous, O.
    Rahman, M.
    Meissner, B.
    Thompson, H.
    Tang, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 258 - 258
  • [2] No superiority of infliximab (INF) plus methotrexate (MTX) over INF alone in the treatment of ankylosing spondylitis (AS):: Results of a one-year randomized prospective study
    Breban, M
    Ravaud, P
    Claudepierre, P
    Baron, G
    Hudry, C
    Euller-Ziegler, L
    Pham, T
    Flipo, RM
    Chary-Valckenaere, I
    Marcelli, C
    Perdriger, A
    Le Loët, X
    Wendling, D
    Fautrel, B
    Fournie, B
    Combe, B
    Gaudin, P
    Saraux, A
    Mariette, X
    Baleydier, A
    Dougados, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S214 - S215
  • [3] An Indirect Comparison and Cost per Responder Analysis of Adalimumab, Methotrexate (MTX) and Apremilast in the Treatment of MTX-naive Psoriatic Arthritis (PsA) Patients
    Strand, Vibeke
    Griffith, Jenny
    Betts, Keith
    Friedman, Alan
    Signorovitch, James
    Ganguli, Arijit
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S686 - S686
  • [4] Remission Induction by Etanercept (ETN) Plus Methotrexate (MTX) Combination Therapy Versus ETN Monotherapy in Patients with Active Rheumatoid Arthritis Despite MTX Treatment
    Kameda, Hideto
    Ueki, Ukitaka
    Saito, Kazuyoshi
    Nagaoka, Shouhei
    Hidaka, Toshihiko
    Atsumi, Tatsuya
    Tsukano, Michishi
    Kasama, Tsuyoshi
    Shiozawa, Shunichi
    Tanaka, Yoshiya
    Kanbe, Katsuaki
    Sato, Eri
    Yamanaka, Hisashi
    Takeuchi, Tsutomu
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S855 - S855
  • [5] HEALTH CARE COSTS IN PSORIATIC ARTHRITIS (PSA) PATIENTS NEWLY INITIATED ON A BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUG (DMARDS) OR METHOTREXATE (MTX)
    Zhang, F.
    Hiscock, R.
    Curtis, J.
    VALUE IN HEALTH, 2012, 15 (07) : A523 - A523
  • [6] RITUXIMAB PLUS METHOTREXATE (MTX) INHIBITS JOINT DAMAGE AND IMPROVES CLINICAL OUTCOMES IN PATIENTS WITH EARLY, ACTIVE RHEUMATOID ARTHRITIS (RA) WHO ARE NAIVE TO MTX
    Tak, Paul P.
    Rigby, William
    Rubbert, Andrea
    Peterfy, Charles
    van Vollenhoven, Ronald F.
    Stohl, William
    Hessey, Eva
    Chen, Annie
    Tyrrell, Helen
    Shaw, Tim
    RHEUMATOLOGY, 2010, 49 : I4 - I4
  • [7] Etanercept (ETA) vs infliximab (INF): A comparison of efficacy in controlling rheumatoid arthritis (RA) flares during the first year of therapy and the year prior to their use
    Yazici, Y
    Erkan, D
    Kulman, I
    Schwartzman, S
    Harrison, MJ
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S81 - S81
  • [8] DOUBLE-BLIND COMPARATIVE STUDY OF RADIOGRAPHIC PROGRESSION OF ETANERCEPT (E) AND METHOTREXATE (MTX), ALONE AND COMBINED (E plus MTX), IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (TEMPO TRIAL)
    van der Heijde, D.
    Klareskog, L.
    DeJager, J.
    Gough, A.
    Kalden, J.
    Malaise, M.
    Mola, E. Martin
    Pavelka, K.
    Sany, J.
    Settas, L.
    Wajdula, J.
    Pedersen, R.
    Fatenejad, S.
    Sanda, M.
    Singh, A.
    RHEUMATOLOGY, 2004, 43 : 37 - 37
  • [9] Comparison of efficacy and safety of infliximab (INF), etanercept (ETN) and adalimumab (ADA) in psoriatic arthritis patients who experienced an inadequate response to previous disease modifying antirheumatic drugs
    Scarpa, Raffaele
    Atteno, Mariangela
    Costa, Luisa
    Peluso, Rosario
    Lofrano, Mariana
    Iervolino, Salvatore
    Caso, Francesco
    Spano, Angelo
    Manguso, Francesco
    Del Puente, Antonio
    RHEUMATOLOGY, 2008, 47 : II68 - II68
  • [10] GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
    Vieira-Sousa, Elsa
    Alves, Pedro
    Rodrigues, Ana M.
    Teixeira, Filipa
    Tavares-Costa, Jose
    Bernardo, Alexandra
    Pimenta, Sofia
    Pimentel-Santos, Fernando M.
    Gomes, Joao Lagoas
    Aguiar, Renata
    Pinto, Patricia
    Videira, Taciana
    Catita, Cristina
    Santos, Helena
    Borges, Joana
    Sequeira, Graca
    Ribeiro, Celia
    Teixeira, Lidia
    Avila-Ribeiro, Pedro
    Martins, Fernando M.
    Canhao, Helena
    McInnes, Iain B.
    Ribeiro, Ruy M.
    Fonseca, Joao Eurico
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (04) : 490 - 498
12